Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 5 Issue 3, March 2009

Editorial

Top of page ⤴

Research Highlight

Top of page ⤴

Practice Point

Top of page ⤴

Viewpoint

  • Increasing demand for fertility treatment seems to correlate with declining semen quality among young men. The factors that cause impaired male reproductive capacity remain to be elucidated. Here, Nordström Joensen et al. suggest that early environmental exposure to endocrine disruptors could promote development of conditions such as testicular dysgenesis syndrome.

    • Ulla Nordström Joensen
    • Niels E Skakkebæk
    • Niels Jørgensen
    Viewpoint
  • Oral and transdermal estrogen therapies are both routinely used to treat menopausal symptoms, but there are multiple differences between their physiological effects. The author of this Viewpoint compares the pharmacodynamics of oral and nonoral estradiol therapies, and discusses the most important risk factors to consider when using either administration route.

    • James A Simon
    Viewpoint
  • Idiopathic short stature (ISS) describes a group of conditions associated with subnormal growth in the absence of an obvious cause. ISS represents an important problem in pediatric endocrinology; however, its heterogeneous nature can make clinical management difficult. Here, the possible merits of growth-hormone therapy for children with ISS are discussed.

    • Martin O Savage
    Viewpoint
Top of page ⤴

Review Article

  • Diabetic dyslipidemia, characterized by low HDL cholesterol level and high levels of triglyceride and small dense, LDL cholesterol, greatly increases the risk of cardiovascular disease. Given the complexity of the dyslipidemic profile, multiple agents are often required to achieve therapeutic goals. This Review discusses the use of various pharmacological agents as well as lifestyle changes for the treatment of dyslipidemia in diabetes mellitus.

    • Arshag D Mooradian
    Review Article
  • The rapid obesity surge in industrialized countries is attributed to genetic susceptibility and environmental factors; however, the primary defects that lead to obesity are still largely unknown. This Review summarizes our current knowledge about the neuronal populations and intracellular signaling molecules that are involved in maintaining normal body weight.

    • Roberto Coppari
    • Giorgio Ramadori
    • Joel K Elmquist
    Review Article
Top of page ⤴

Case Study

  • Generalized arterial calcification of infancy is a rare and often fatal genetic disorder, for which no formalized treatment approach exists. This article describes a case where treatment with nitrogen-containing bisphosphonates resulted in normalization of the arterial structure.

    • Kim A Ramjan
    • Tony Roscioli
    • Craig FJ Munns
    Case Study
  • Cyclic Cushing syndrome is a rare disorder characterized by periodic fluctuations in adrenal cortisol secretion, with phases of hypercortisolism alternating with periods of normal or low cortisol production. This Case Study discusses diagnostic challenges and treatment options in a patient with cyclic Cushing syndrome due to an ectopic pituitary adenoma.

    • Rahfa K Zerikly
    • Esin Eray
    • Amir H Hamrahian
    Case Study
Top of page ⤴

Erratum

Top of page ⤴

Search

Quick links